Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor 51B2 is a transmembrane G protein-coupled receptor expressed in the olfactory epithelium, where it interacts with odorant molecules to initiate a neuronal response that leads to the perception of smell. OR51B2 shares the characteristic 7-transmembrane domain architecture with other olfactory and neurotransmitter/hormone GPCRs and is derived from a large single coding-exon gene family. Notably, as of recent knowledge, OR51B2 remains an orphan receptor, meaning no specific odorant ligands are identified for this protein. In some individuals, OR51B2 is a segregating pseudogene, indicating allelic variation in functionality. There is no evidence for therapeutic targeting or a direct role in common diseases.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor 51B2 (OR51B2).